The store will not work correctly when cookies are disabled.
5-Bromo-4-(2-ethoxyphenoxy)-N-(m-tolyl)pyrimidin-2-amine
ID: ALA4783288
PubChem CID: 162666500
Max Phase: Preclinical
Molecular Formula: C19H18BrN3O2
Molecular Weight: 400.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOc1ccccc1Oc1nc(Nc2cccc(C)c2)ncc1Br
Standard InChI: InChI=1S/C19H18BrN3O2/c1-3-24-16-9-4-5-10-17(16)25-18-15(20)12-21-19(23-18)22-14-8-6-7-13(2)11-14/h4-12H,3H2,1-2H3,(H,21,22,23)
Standard InChI Key: ZHUWBZNOBXMXNS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
11.6526 -25.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6515 -26.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3662 -27.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3645 -25.3869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0799 -25.7961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0787 -26.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7955 -27.0444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7980 -25.3783 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
14.5194 -25.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5181 -26.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2341 -27.0408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9520 -26.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9493 -25.7947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2326 -25.3847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6671 -27.0382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3809 -26.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0945 -27.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8079 -26.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8072 -25.8022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0871 -25.3909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3767 -25.8061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5228 -27.0399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3659 -27.8650 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6514 -28.2772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9370 -27.8645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
3 23 1 0
23 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.28 | Molecular Weight (Monoisotopic): 399.0582 | AlogP: 5.48 | #Rotatable Bonds: 6 |
Polar Surface Area: 56.27 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.95 | CX Basic pKa: 1.55 | CX LogP: 5.74 | CX LogD: 5.74 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -1.41 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |